These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 23179888)

  • 21. [¹⁸F]fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography imaging in oncology: initial staging and evaluation of cancer therapy.
    Pauwels EK; Coumou AW; Kostkiewicz M; Kairemo K
    Med Princ Pract; 2013; 22(5):427-37. PubMed ID: 23363934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Importance of PET/CT for imaging of colorectal cancer].
    Meinel FG; Schramm N; Haug AR; Graser A; Reiser MF; Rist C
    Radiologe; 2012 Jun; 52(6):529-36. PubMed ID: 22618625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [18F]FDG PET/CT imaging of colorectal cancer: a pictorial review.
    Chowdhury FU; Shah N; Scarsbrook AF; Bradley KM
    Postgrad Med J; 2010 Mar; 86(1013):174-82. PubMed ID: 20237012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic performance of PET/CT with tracers other than F-18-FDG in oncology: an evidence-based review.
    Treglia G; Sadeghi R; Del Sole A; Giovanella L
    Clin Transl Oncol; 2014 Sep; 16(9):770-5. PubMed ID: 24647843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical applications of positron emission tomography-computed tomography in oncology.
    Kumar R; Halanaik D; Malhotra A
    Indian J Cancer; 2010; 47(2):100-19. PubMed ID: 20448371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (18)F-Fluorodeoxyglucose PET/MR Imaging in Lymphoma.
    Platzek I
    PET Clin; 2016 Oct; 11(4):363-73. PubMed ID: 27593243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Applications of Fluorodeoxyglucose PET/Computed Tomography in the Assessment and Prediction of Radiation Therapy-related Complications.
    Houshmand S; Boursi B; Salavati A; Simone CB; Alavi A
    PET Clin; 2015 Oct; 10(4):555-71. PubMed ID: 26384600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PET-CT in oncology.
    Purandare NC; Rangarajan V
    J Postgrad Med; 2010; 56(2):103-8. PubMed ID: 20622389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET/CT of cancer patients: part 1, pancreatic neoplasms.
    Dibble EH; Karantanis D; Mercier G; Peller PJ; Kachnic LA; Subramaniam RM
    AJR Am J Roentgenol; 2012 Nov; 199(5):952-67. PubMed ID: 23096166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of positron emission tomography-computed tomography in pulmonary neoplasms.
    Shreve P; Faasse T
    Radiol Clin North Am; 2013 Sep; 51(5):767-79. PubMed ID: 24010905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tracers in oncology - preclinical and clinical evaluation].
    Krause BJ; Schwarzenböck S; Schwaiger M
    Nuklearmedizin; 2010; 49 Suppl 1():S41-5. PubMed ID: 21152689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PET/CT, MR, and PET/MR in Lymphoma and Melanoma.
    Schwenzer NF; Pfannenberg AC
    Semin Nucl Med; 2015 Jul; 45(4):322-31. PubMed ID: 26050659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of positron emission tomography in urological oncology.
    Rioja J; Rodríguez-Fraile M; Lima-Favaretto R; Rincón-Mayans A; Peñuelas-Sánchez I; Zudaire-Bergera JJ; Parra RO
    BJU Int; 2010 Dec; 106(11):1578-93. PubMed ID: 21078036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PET and PET/CT in the clinical management of colorectal cancer.
    El-Maghraby T
    Gulf J Oncolog; 2009 Jul; (6):8-16. PubMed ID: 20194086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positron Emission Tomography (PET) and breast cancer in clinical practice.
    Lavayssière R; Cabée AE; Filmont JE
    Eur J Radiol; 2009 Jan; 69(1):50-8. PubMed ID: 18814983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical applications of positron emission tomography in sarcoma management.
    Quak E; van de Luijtgaarden AC; de Geus-Oei LF; van der Graaf WT; Oyen WJ
    Expert Rev Anticancer Ther; 2011 Feb; 11(2):195-204. PubMed ID: 21342039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FDG-PET/CT: new horizons in anal cancer.
    Grigsby PW
    Gastroenterol Clin Biol; 2009 May; 33(5):456-8. PubMed ID: 19394179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PET-CT in radiation oncology: the impact on diagnosis, treatment planning, and assessment of treatment response.
    Heron DE; Andrade RS; Beriwal S; Smith RP
    Am J Clin Oncol; 2008 Aug; 31(4):352-62. PubMed ID: 18845994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [FDG-PET/CT in oncology. German Guideline].
    Krause BJ; Beyer T; Bockisch A; Delbeke D; Kotzerke J; Minkov V; Reiser M; Willich N
    Nuklearmedizin; 2007; 46(6):291-301. PubMed ID: 18084685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of FDG-PET/CT in gynaecological cancers.
    Rockall AG; Cross S; Flanagan S; Moore E; Avril N
    Cancer Imaging; 2012 Mar; 12(1):49-65. PubMed ID: 22391444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.